Publication:

A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome

Loading...
Thumbnail Image

Open/View Files

Date

2016

Journal Title

Journal ISSN

Volume Title

Publisher

Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Frohlich, J., D. Senturk, V. Saravanapandian, P. Golshani, L. T. Reiter, R. Sankar, R. L. Thibert, et al. 2016. “A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome.” PLoS ONE 11 (12): e0167179. doi:10.1371/journal.pone.0167179. http://dx.doi.org/10.1371/journal.pone.0167179.

Abstract

Background: Duplications of 15q11.2-q13.1 (Dup15q syndrome) are highly penetrant for autism spectrum disorder (ASD). A distinct electrophysiological (EEG) pattern characterized by excessive activity in the beta band has been noted in clinical reports. We asked whether EEG power in the beta band, as well as in other frequency bands, distinguished children with Dup15q syndrome from those with non-syndromic ASD and then examined the clinical correlates of this electrophysiological biomarker in Dup15q syndrome. Methods: In the first study, we recorded spontaneous EEG from children with Dup15q syndrome (n = 11), age-and-IQ-matched children with ASD (n = 10) and age-matched typically developing (TD) children (n = 9) and computed relative power in 6 frequency bands for 9 regions of interest (ROIs). Group comparisons were made using a repeated measures analysis of variance. In the second study, we recorded spontaneous EEG from a larger cohort of individuals with Dup15q syndrome (n = 27) across two sites and examined age, epilepsy, and duplication type as predictors of beta power using simple linear regressions. Results: In the first study, spontaneous beta1 (12–20 Hz) and beta2 (20–30 Hz) power were significantly higher in Dup15q syndrome compared with both comparison groups, while delta (1–4 Hz) was significantly lower than both comparison groups. Effect sizes in all three frequency bands were large (|d| > 1). In the second study, we found that beta2 power was significantly related to epilepsy diagnosis in Dup15q syndrome. Conclusions: Here, we have identified an electrophysiological biomarker of Dup15q syndrome that may facilitate clinical stratification, treatment monitoring, and measurement of target engagement for future clinical trials. Future work will investigate the genetic and neural underpinnings of this electrophysiological signature as well as the functional consequences of excessive beta oscillations in Dup15q syndrome.

Description

Research Data

Keywords

Bioassays and Physiological Analysis, Electrophysiological Techniques, Brain Electrophysiology, Electroencephalography, Biology and Life Sciences, Physiology, Electrophysiology, Neurophysiology, Medicine and Health Sciences, Neuroscience, Brain Mapping, Diagnostic Medicine, Clinical Neurophysiology, Imaging Techniques, Neuroimaging, Neurology, Epilepsy, Biochemistry, Biomarkers, Genetics, Genetic Oscillators, Pharmacology, Drugs, Anticonvulsants, Anatomy, Head, Scalp, Psychology, Developmental Psychology, Autism Spectrum Disorder, Social Sciences, Clinical Genetics

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories